Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FEC vs AC in Node-Negative Breast Cancer
NCT00087178Phase 3Completed
- Sponsor
- NSABP Foundation
- Start
- May 2004
- Primary completion
- Mar 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 3 trial of epirubicin, fluorouracil in breast cancer, sponsored by NSABP Foundation. Started May 2004; status: completed.
02
Drugs
epirubicinfluorouracil
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00087178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087178.